4,000 volunteers are set to be recruited to the latest vaccine study running in the UK, examining a new COVID-19 vaccine candidate.

Developed by specialty vaccine company Valneva, the vaccine is being manufactured at the company’s site in Livingston, West Lothian. It is the only inactivated, adjuvanted (an ingredient to create a strong immune response) COVID-19 vaccine in clinical development in Europe.

The study will be running across 22 National Institute for Health Research (NIHR) sites in England, and two sites in Scotland, and is open to healthy adults who have not had a previous COVID-19 vaccine.

For more info, please follow the link below: